Cubist Systematic Strategies »

Terns Pharmaceuticals shares owned by Cubist Systematic Strategies

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Cubist Systematic Strategies from 13F filings

Historical chart of Cubist Systematic Strategies investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Cubist Systematic Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Cubist Systematic Strategies

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.6M 187k 8.34
2024-03-31 $2.1k 327 6.56
2023-09-30 $679k 135k 5.03
2023-03-31 $241k 20k 11.84
2022-12-31 $50k 4.9k 10.18
2022-06-30 $6.0k 2.4k 2.47
2022-03-31 $4.0k 1.2k 3.33

More positions owned by Cubist Systematic Strategies

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Netflix (NFLX)
Microsoft Corporation (MSFT)
Super Micro Computer Call Option (SMCI)
General Motors Company (GM)
Spotify Technology S A SHS (SPOT)
Meta Platforms Cl A (META)
Micron Technology Call Option (MU)
Arm Holdings Sponsored Ads Call Option (ARM)
Intel Corporation Call Option (INTC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Snowflake Cl A (SNOW)
Tesla Motors Call Option (TSLA)

View all positions for Cubist Systematic Strategies

Top funds holding Terns Pharmaceuticals

OrbiMed Advisors
Deep Track Capital
Soleus Capital Management
BlackRock
BlackRock
Citadel Advisors
VR Adviser
Schonfeld Strategic Advisors
Point72 Asset Management
Vanguard Group
Avidity Partners Management
Driehaus Capital Management
ExodusPoint Capital Management
T. Rowe Price Associates
Geode Capital Management

View all funds holding Terns Pharmaceuticals